Vertigo, characterized by a sensation of moving or spinning, is a prevalent symptom that often presents in clinical practice. This symptom can be indicative of various underlying conditions, both benign and severe, necessitating a comprehensive and systematic approach to diagnosis and management.
Vertigo is a subtype of dizziness, often mistaken for a disease, but it is merely a symptom. It is typically associated with disorders in the vestibular system, including the inner ear and brain. Vertigo is classified into two types: peripheral, related to problems in the inner ear, and central, connected to issues in the brain.
Effective management of vertigo begins with a thorough clinical evaluation. A detailed history taking, focusing on the onset, duration, frequency, and associated symptoms, is crucial. Physical examination, including specific vestibular tests like the Dix-Hallpike maneuver, can help differentiate between peripheral and central vertigo.
Diagnostic approaches should be tailored based on the clinical assessment. For suspected peripheral vertigo, audiometry and vestibular function tests are useful. In cases of suspected central vertigo, neuroimaging techniques such as MRI or CT scan may be required. Furthermore, blood tests can help identify metabolic causes of vertigo.
Treatment should be individualized and directed towards the underlying cause. For benign paroxysmal positional vertigo (BPPV), repositioning maneuvers are effective. Pharmacological therapy, including vestibular suppressants and antiemetics, can be used for symptomatic relief. In refractory cases, surgical interventions may be considered.
Vertigo, despite being a common symptom, can often be complex and challenging to manage. A comprehensive clinical approach, encompassing a detailed history, physical examination, appropriate diagnostic testing, and tailored treatment, is essential for effective management. Ongoing research into the pathophysiology and treatment of vertigo promises to further enhance our understanding and management of this challenging symptom.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation